CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,309,000 | -65.5% | 587,626 | +30.6% | 1.28% | -62.0% |
Q2 2019 | $6,692,000 | +8.1% | 450,000 | +80.4% | 3.37% | +24.6% |
Q1 2019 | $6,190,000 | +473.7% | 249,389 | +315.0% | 2.71% | +386.2% |
Q4 2018 | $1,079,000 | -55.6% | 60,100 | +30.6% | 0.56% | -63.4% |
Q1 2018 | $2,429,000 | -10.7% | 46,001 | +15.0% | 1.52% | -23.8% |
Q4 2017 | $2,720,000 | – | 40,000 | – | 2.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |